Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP8488.RATgNLY8yjoejKnxWvjpTacWM9Iu7qlN4ywHol2aJMyUA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_curated type ECO_0000205 NP8488.RATgNLY8yjoejKnxWvjpTacWM9Iu7qlN4ywHol2aJMyUA130_provenance.
- source_evidence_curated label "DisGeNET evidence - CURATED" NP8488.RATgNLY8yjoejKnxWvjpTacWM9Iu7qlN4ywHol2aJMyUA130_provenance.
- source_evidence_curated comment "Gene-disease associations manually curated." NP8488.RATgNLY8yjoejKnxWvjpTacWM9Iu7qlN4ywHol2aJMyUA130_provenance.
- NP8488.RATgNLY8yjoejKnxWvjpTacWM9Iu7qlN4ywHol2aJMyUA130_assertion description "[Crizotinib is a dual-specific inhibitor of ALK/Met and inhibits proliferation of neuroblastoma cells harboring R1275Q-mutated ALK or amplified wild-type ALK, but not cells harboring F1174L.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP8488.RATgNLY8yjoejKnxWvjpTacWM9Iu7qlN4ywHol2aJMyUA130_provenance.
- NP8488.RATgNLY8yjoejKnxWvjpTacWM9Iu7qlN4ywHol2aJMyUA130_assertion evidence source_evidence_curated NP8488.RATgNLY8yjoejKnxWvjpTacWM9Iu7qlN4ywHol2aJMyUA130_provenance.
- NP8488.RATgNLY8yjoejKnxWvjpTacWM9Iu7qlN4ywHol2aJMyUA130_assertion SIO_000772 22588779 NP8488.RATgNLY8yjoejKnxWvjpTacWM9Iu7qlN4ywHol2aJMyUA130_provenance.
- NP8488.RATgNLY8yjoejKnxWvjpTacWM9Iu7qlN4ywHol2aJMyUA130_assertion wasDerivedFrom ctd_human-20130708 NP8488.RATgNLY8yjoejKnxWvjpTacWM9Iu7qlN4ywHol2aJMyUA130_provenance.
- NP8488.RATgNLY8yjoejKnxWvjpTacWM9Iu7qlN4ywHol2aJMyUA130_assertion wasGeneratedBy ECO_0000218 NP8488.RATgNLY8yjoejKnxWvjpTacWM9Iu7qlN4ywHol2aJMyUA130_provenance.
- ctd_human-20130708 importedOn "2013-07-24" NP8488.RATgNLY8yjoejKnxWvjpTacWM9Iu7qlN4ywHol2aJMyUA130_provenance.